The Europe Viscosupplementation Market is expected to reach USD 5.6 billion in 2024 and grow to USD 13.0 billion by 2033 at a CAGR of 9.8%. Rising prevalence of osteoarthritis and increasing demand for minimally invasive treatments are driving market growth across Europe. Viscosupplementation therapies using hyaluronic acid are gaining popularity for improving joint lubrication and mobility. Countries such as Germany, France, and the UK are major contributors due to strong healthcare infrastructure and orthopedic expertise. Advancements in treatment formulations and growing patient awareness are also supporting market expansion. Increasing adoption of non-surgical therapies continues to boost demand across the region.
